AUGTYROTM (repotrectinib) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread within your chest or to other parts of the body and is caused by an abnormal ROS1 gene.
It is not known if AUGTYRO is safe and effective in children.
1%-2% of adults with non-small cell lung cancer (NSCLC) are diagnosed with an abnormal ROS1 gene. AUGTYRO is a treatment tailored to treat it, whether you are newly diagnosed or have been previously treated.
You’re not alone. Sign up for this complimentary program to learn about support and advocacy groups and get tools to help you during your journey.